Black women living in states with worse health rankings had higher relative risks of breast cancer incidence (1.14 [1.03-1.26]) and mortality (1.27 [1.05-1.53]). There was no significant association between state health rankings and prostate cancer incidence and mortality in the US.Conclusions:...
Accessed March 23, 2023. https://news.va.gov/92022/diversity-equity-inclusion-va-goals/ 30. Hudson MA, Luo S, Chrusciel T, et al. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans? Urol Oncol. 2014;32(1):34.e9-34....
Prostate cancer (PCa) is the second most frequent type of cancer found in men worldwide, with around one in nine men being diagnosed with PCa within their lifetime. PCa often shows no symptoms in its early stages and its diagnosis techniques are either invasive, resource intensive, or has l...
Global Prostate Cancer Diagnostics Market was valued atUS$ 4.17 Billionin2023and the industry is projected to grow at aCAGRof12.35%between2024and2032, reaching an estimated value ofUS$ 11.89 Billionby2032. A key driver of the market's expansion is the rising incidence of prostate cancer. Prosta...
The incidence of prostate cancer (PCa) among Asian males has been dramatically rising even though it is still lower compared to that in western countries1. In 2015, PCa became the most common cancer type among Japanese males2. The best-known risk factor for PCa is family history3. A patien...
被引量: 0发表: 2023年 HAROW: Is there a need for a radical change in the treatment of Prostate Cancer? BACKGROUND\nProstate cancer is one of the most prevalent cancers in men, leading to the second most common cause of death in men. Despite the availability ... Heike,Schön,and,.....
Prostate cancer is a common malignant tumor in elderly men in western countries. In the past decade, the incidence and mortality of prostate cancer in China have shown a rapid upward trend. With the changes of social economy, life style and the progress of diagnosis and treatment, the epidemio...
The induction of “protective autophagy” by cancer cells is a well-known response to stress or anti-cancer drug treatment. This can be overcome by adding an autophagy inhibitor drug, such as propranolol. (DCA synergy with the autophagy inhibitor propranolol is discussed below.) In addition, Dr...
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer Article Open access 06 March 2023 Facts Prostate cancer is second only to lung cancer in male incidence. There is no effective treatment for distant metastasis and castration resistan...
Geographic variation may be attributed to the different incidence rates around the world. For most men, prostate cancer is slow-growing, does not lead to clinical signs in the early stage and is usually detected by routine testing5. However, in some men, PCa progresses quickly and can cause ...